There has been a lot of research devoted to identifying phenotypic differences between KRAS, NRAS, and HRAS mutations, but large cohort studies have not been able to verify distinct oncogenic effects among KRAS G12 subtypes. https://t.co/B4VNGiMD8y
A Comparative Analysis of Individual RAS Mutations in Cancer Biology https://t.co/C9GbbtHEU0
RT @Run_itt: @manjuggm @kRasKickers @PaolaRGSC @pashtoonkasi @CathyEngMD @agrothey @JFreemanDaily @ShaalanBeg Should be, it’s a missense mu…
@manjuggm @kRasKickers @PaolaRGSC @pashtoonkasi @CathyEngMD @agrothey @JFreemanDaily @ShaalanBeg Should be, it’s a missense mutation with a change from Glycine to Tryptophan. Checkout https://t.co/nq7Te9scWu